
Bioorganic and Medicinal Chemistry Letters p. 3577 - 3582 (1998)
Update date:2022-08-04
Topics:
Chambers
Antognoli
Cheng
Kuperman
Liston
Marfat
Owens
Pillar
Shirley
Watson
A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor antagonists Zafirlukast (1) and Pranlukast (2).
View MoreSuzhou BEC Fine Chemicals Co., Ltd.
website:http://www.bek.com.cn
Contact:0512-68095917 18913193865
Address:6, Jin Shan Road, Suzhou New District, 215011 China Suzhou Nations Pharmaceutical Innovation Center Inside
Qingdao Kylin Trading Co., Ltd.
Contact:0086-532-68979884/58972912/68972263/65/88171519
Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.
Huangshan Violet Biological Technology Co., Ltd
Contact:+86-559-2335676
Address:16-201 JinShanYuan,JiangNan New City,TunXi District,HuangShan City,AnHui Province,China
Yuan Shi(SuQian)Biotechnology Co.,Ltd
website:http://www.yuanshibio.com
Contact:+86-527-84226672
Address:jiangsu suqian
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Doi:10.1021/ja4098803
(2013)Doi:10.1021/ja00217a003
(1988)Doi:10.1016/j.tetlet.2013.10.156
(2014)Doi:10.1021/ja056505c
(2006)Doi:10.1016/j.tet.2020.131635
(2020)Doi:10.1002/ejoc.201801318
(2018)